Lennart Jungersten blir vd för Boehringer Ingelheim Sverige

Lennart Jungersten har i i över ett decennium arbetat för Boehringer Ingelheim i olika länder och på olika kontinenter. Nu återvänder han hem och utses till vd ...

Uppsala-based company wins important patent dispute – but the decision is subject to appeal

A US district court has ruled in favour of Orexo in a dispute over the patent protecting the Swedish company’s drug Zubsolv, developed for treating patients wit...

EXCL Gantry Kit Improve Automated Lab Applications

We’re excited to introduce a new product that improves precision and throughput in life science applications. The EXCL multi-axis gantry kit lowers engineering ...

How to become globally competitive

Here Gunilla Osswald from BioArctic share her experience of scaling up and be competative on the global arena.

Lucy Robertshaw: There is a bio revolution happening right now

Lucy Robertshaw is both proud and excited to be taking the baton of moderating this year’s Pharma Outsourcing event.

Swedish and Danish Life Science – are there still untapped synergies?

With the increasing developments in life sciences over the past decade and strong support for the sector’s strategic importance from both the Sweden and Danish ...

Genentech ingår licensavtal inom autoimmuna sjukdomar

Roches amerikanska dotterbolag Genentech har ingått ett licens- och samarbetsavtal med Repertoire Immune Medicines med syfte att utveckla T-cellsinriktade behan...

Lista: Så mycket betalar Big Pharma sina toppar

29,2 miljoner dollar, motsvarande drygt 284 miljoner svenska kronor. Så mycket fick den högst betalda läkemedels-vd:n i ersättning ifjol. Nyfiken på vad läkemed...

The Swedish government is to increase its investment in cancer care

The Swedish government wants to invest more in cancer and paediatric cancer care and proposes to allocate SEK 500 million per year for this purpose in the coming years.

How to optimise your liquid handling results

In dispensing or pipetting applications in laboratory automation, it is important to obtain reliable results, which are analysed by calculating the accuracy and...

Sanofi backar efter besvikelse i KOL-studie

Blandade resultat för KOL-behandlingen Itepekimab i två fas III-studier fick Sanofis och Regenerons aktier att backa ordentligt på fredagen.

Inga spår av coronavirus när Londons tunnelbana undersöktes

En nyligen genomförd stickprovsundersökning i Londons tunnelbana visade inga spår av sars-cov-2.

Enabling 3D Multiplexing Spatial Omics Workflows in Neuroscience

Case study by ZEISS Microscopy.

J&J har fått en ny Nordenchef

Johnson & Johnson Innovative Medicine har utsett Mario Klesse till ny Norden- och Sverigechef.

Nanexa develops depot formulation of the diabetes and obesity drug Saxenda

Uppsala-based company Nanexa has signed an agreement with a German contract research company to start a clinical study with a monthly depot of liraglutide. The ...

EU Pharmaceutical Legislation Reform

The EU's Pharmaceutical Legislation Reform, proposed by the commission within the European Health Union, aims to establish a citizen-centric framework to enhanc...

Life Science-podden: The perfect moment for an IPO

When is the right time to go for an IPO? What strategy is recommended in today´s rather uncertain business climate when it comes to taking your life science company public?

Eternal Rye – Improving Plant Breeding Methods

User story from Martin Luther University Halle.

Hon är ny generaldirektör för Läkemedelsverket

Ann Lindberg utses av regeringen till ny generaldirektör för Läkemedelsverket.

Drug development creates new challenges for regulators

Study: Semaglutide tablet produces weight loss

The pharmaceutical semaglutide is effective for weight loss even when given in tablet form, according to a phase 3 study.

Uncertainty about the government’s life science work

The government’s national coordinator for life science, Jenni Nordborg, left her position almost four months ago. No one has yet succeeded her, and now question...

Isländskt läkemedelsbolag noterar sig på Stockholmsbörsen - ”Naturligt steg”

Ett av Islands största företag, läkemedelsbolaget Alvotech, planerar att notera sig på Nasdaq Stockholm.

Ny ordförande för Atlas Antibodies

Åsa Riisberg, styrelseproffs och tidigare partner i EQT, tar över ordförandeklubban i Atlas Antibodies.